Inogen Inc (NASDAQ:INGN) EVP Matt Scribner sold 2,500 shares of the stock in a transaction dated Thursday, March 15th. The stock was sold at an average price of $127.95, for a total transaction of $319,875.00. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.
Matt Scribner also recently made the following trade(s):
- On Tuesday, January 16th, Matt Scribner sold 2,500 shares of Inogen stock. The stock was sold at an average price of $116.17, for a total transaction of $290,425.00.
Shares of Inogen stock traded down $4.07 on Monday, hitting $125.02. 105,306 shares of the stock traded hands, compared to its average volume of 144,937. Inogen Inc has a twelve month low of $73.68 and a twelve month high of $134.97. The firm has a market capitalization of $2,723.18, a P/E ratio of 131.60, a price-to-earnings-growth ratio of 3.59 and a beta of 1.03.
Several equities research analysts have recently weighed in on INGN shares. Zacks Investment Research upgraded shares of Inogen from a “hold” rating to a “buy” rating and set a $128.00 target price for the company in a research note on Tuesday, January 9th. BidaskClub upgraded shares of Inogen from a “hold” rating to a “buy” rating in a research note on Saturday, February 10th. Three analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company. Inogen has a consensus rating of “Buy” and a consensus price target of $107.29.
Institutional investors and hedge funds have recently made changes to their positions in the company. Lenox Wealth Advisors Inc. acquired a new stake in shares of Inogen during the fourth quarter worth about $100,000. Steward Partners Investment Advisory LLC boosted its stake in shares of Inogen by 1,000.0% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 1,100 shares of the medical technology company’s stock worth $130,000 after buying an additional 1,000 shares during the period. Simplex Trading LLC purchased a new position in Inogen during the fourth quarter worth about $153,000. LS Investment Advisors LLC raised its holdings in Inogen by 138.6% during the fourth quarter. LS Investment Advisors LLC now owns 1,515 shares of the medical technology company’s stock worth $180,000 after purchasing an additional 880 shares in the last quarter. Finally, Everence Capital Management Inc. purchased a new position in Inogen during the fourth quarter worth about $208,000. Institutional investors and hedge funds own 99.45% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: “Inogen Inc (INGN) EVP Sells $319,875.00 in Stock” was first posted by The Lincolnian Online and is the property of of The Lincolnian Online. If you are viewing this report on another publication, it was stolen and reposted in violation of international trademark & copyright law. The correct version of this report can be read at https://www.thelincolnianonline.com/2018/03/19/inogen-inc-ingn-evp-sells-319875-00-in-stock.html.
Inogen, Inc is a medical technology company. The Company develops, manufactures and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The Company’s Inogen One systems concentrate the air around the patient to offer a single source of supplemental oxygen anytime, anywhere with a portable device.
Receive News & Ratings for Inogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inogen and related companies with MarketBeat.com's FREE daily email newsletter.